Double trouble: When Sonic hedgehog signaling meets TSC inactivation

Cell Cycle

Volumn 9, Issue 3, 2010, Pages 456-459

  Bhatia, Bobby ^a   Nahlé, Zaher ^b,c   Kenney, Anna Marie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Lung Cancer Center   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cerebellum; Medulloblastoma; mTOR; p27kip1; Sonic hedgehog; TSC

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN; SONIC HEDGEHOG PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PREDISPOSITION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; NONHUMAN; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS; ANIMAL; BIOLOGICAL MODEL; GENE SILENCING; METABOLISM; MOUSE; PATHOLOGY;

ERINACEIDAE; MAMMALIA; MUS;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE SILENCING; HEDGEHOG PROTEINS; HUMANS; MEDULLOBLASTOMA; MICE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 77951898362     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.3.10532     Document Type: Article

References (37)

1. Knoepfler PS, Kenney AM. Neural precursor cycling at sonic speed: N-Myc pedals, GSK-3 brakes. Cell Cycle 2006; 5:47-52.
2. Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev 2003; 13:34-42. (Pubitemid 36143925)
3. Eberhart CG. Even cancers want commitment: lineage identity and medulloblastoma formation. Cancer Cell 2008; 14:105-7.
4. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J, et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997; 57:2085-8. (Pubitemid 27247016)
5. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997; 57:842-5. (Pubitemid 27098006)
6. Hartmann W, Koch A, Brune H, Waha A, Schuller U, Dani I, et al. Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am J Pathol 2005; 166:1153-62. (Pubitemid 40524439)
7. Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004; 23:3151-71. (Pubitemid 38638827)
8. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37:19-24. (Pubitemid 40070934)
9. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006; 355:1345-56.
10. Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem 1997; 272:29301-8. (Pubitemid 27498223)
11. Soucek T, Rosner M, Miloloza A, Kubista M, Cheadle JP, Sampson JR, et al. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression. Oncogene 2001; 20:4904-9. (Pubitemid 32803162)
12. Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 2007; 16:1541-56.
13. Rosner M, Hengstschlager M. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. J Biol Chem 2004; 279:48707-15. (Pubitemid 39625747)
14. Miyazawa K, Himi T, Garcia V, Yamagishi H, Sato S, Ishizaki Y. A role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation. J Neurosci 2000; 20:5756-63. (Pubitemid 30636904)
15. Kip1 and patched-1, collaborate to prevent medulloblastoma. Mol Cancer Res 2009; 7:33-40.
16. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999; 18:1571-83. (Pubitemid 29127070)
17. Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998; 95:1091-6.
18. Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 2007; 21:1731-46.
19. Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 2007; 67:9238-43.
20. Kip1 function in tumorigenesis. Genes Dev 2007; 21:1703-6.
21. Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci USA 2009; 106:9268-73.
22. Larrea MD, Wander SA, Slingerland JM. p27 as Jekyll and Hyde: Regulation of cell cycle and cell motility. Cell Cycle 2009; 8:3455-61.
23. Gilbertson RJ, Clifford SC. PDGFRB is overexpressed in metastatic medulloblastoma. Nat Genet 2003; 35:197-8.
24. Przkora R, Meyer-Puttlitz B, Schmitt O, Berthold F, Nothen M, Krauss J, et al. Analysis of the TSC2 gene in human medulloblastoma. Acta Neuropathol 2001; 102:380-4. (Pubitemid 32894709)
25. Kip1 localization. Cancer Res 2009; 69:7224-34.
26. Kenney AM, Widlund HR, Rowitch DH. Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development 2004; 131:217-28.
27. Parathath SR, Mainwaring LA, Fernandez LA, Campbell DO, Kenney AM. Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors. Development 2008; 135:3291-300.
28. Kim JY, Nelson AL, Algon SA, Graves O, Sturla LM, Goumnerova LC, et al. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Dev Biol 2003; 263:50-66. (Pubitemid 37268003)
29. Pazzaglia S, Tanori M, Mancuso M, Gessi M, Pasquali E, Leonardi S, et al. Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice. Oncogene 2006; 25:5575-80. (Pubitemid 44344108)
30. Zhang HH, Lipovsky AI, Dibble CC, Sahin M, Manning BD. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell 2006; 24:185-97.
31. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499-511. (Pubitemid 28553242)
32. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997; 277:1109-13. (Pubitemid 27371635)
33. Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA, et al. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 2004; 64:7794-800. (Pubitemid 39446912)
34. Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, et al. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res 2008; 68:1768-76. (Pubitemid 351416562)
35. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002; 297:1559-61.
36. Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9:550-62.
37. Scales SJ, de Sauvage FJ. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2009; 30:303-12.